Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4392487 | 1.00 | ALDH1A1 (0.39) | ALDH1A1 | |
| SCHEMBL54952 | 1.00 | ALDH1A1 (0.39) | ALDH1A1 | |
| SCHEMBL1670932 | 1.00 | ALDH1A1 (0.39) | ALDH1A1 | |
| SCHEMBL9518805 | 1.00 | ALDH1A1 (0.39) | ALDH1A1 | |
| SCHEMBL3061 | 1.00 | ALDH1A1 (0.39) | ALDH1A1 | |
| SCHEMBL2896924 | 0.97 | ALDH1A1 (0.37) | ALDH1A1 | |
| SCHEMBL8614862 | 0.97 | ALDH1A1 (0.37) | ALDH1A1 | |
| SCHEMBL11373240 | 0.97 | ALDH1A1 (0.37) | ALDH1A1 | |
| SCHEMBL7652865 | 0.94 | ALDH1A1 (0.39) | ALDH1A1 | |
| SCHEMBL55986 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4330361-A1 | 2,4-DIMETHYLOCTA-2,7-DIEN-4-OL AS AN ODORIFEROUS SUBSTANCE | Symrise AG (DE) | 2024-03-06 | — | — | EP | claimed |
| EP-4305135-A1 | 2,6,6-TRIMETHYL-NORPINAN-2-OL AS AN ODORIFEROUS SUBSTANCE | Symrise AG (DE) | 2024-01-17 | — | — | EP | claimed |
| CN-117203313-A | 2, 4-dimethyloctan-2, 7-dien-4-ol as perfume | 西姆莱斯股份公司 | 2023-12-08 | — | — | CN | claimed |
| CN-116964182-A | 2, 6-trimethyl-pinan-2-ol as fragrance | 西姆莱斯股份公司 | 2023-10-27 | — | — | CN | claimed |
| US-11634659-B2 | Fragrances with rose scent | SYMRISE AG (DE) | 2023-04-25 | — | — | US | claimed |
| US-11603506-B2 | Product comprising a plastic container and a substance composition | SYMRISE AG (DE) | 2023-03-14 | — | — | US | claimed |
| US-20210324300-A1 | NOVEL FRAGRANCES WITH ROSE SCENT | SYMRISE AG (DE) | 2021-10-21 | — | — | US | claimed |
| EP-3826986-A1 | NOVEL ODORANTS HAVING ROSE ODOUR | Symrise AG (DE) | 2021-06-02 | — | — | EP | claimed |
| WO-2020020434-A1 | NOVEL ODORANTS HAVING ROSE ODOUR | SYMRISE AG (DE) | 2020-01-30 | — | — | WO | claimed |
| EP-3507352-A1 | PRODUCT COMPRISING A PLASTIC CONTAINER AND A SUBSTANCE COMPOSITION | Symrise AG (DE) | 2019-07-10 | — | — | EP | claimed |
| WO-2018041354-A1 | PRODUCT COMPRISING A PLASTIC CONTAINER AND A SUBSTANCE COMPOSITION | SYMRISE AG (DE) | 2018-03-08 | — | — | WO | claimed |
| JP-11189611-A | — | — | None | — | — | JP | disclosed |
| JP-11029525-A | — | — | None | — | — | JP | disclosed |
| US-20240209281-A1 | 2,4-DIMETHYLOCTA-2,7-DIEN-4-OL AS AN ODORIFEROUS SUBSTANCE | SYMRISE AG (DE) | 2024-06-27 | — | — | US | disclosed |
| US-20240141254-A1 | 2,6,6-TRIMETHYL-NORPINAN-2-OL AS AN ODORIFEROUS SUBSTANCE | SYMRISE AG (DE) | 2024-05-02 | — | — | US | disclosed |
| US-20100087351-A1 | Perfumes for Linear Citrus Release in Rinse-Off Systems | QUEST INTERNATIONAL SERVICES B.V. (NL) | 2010-04-08 | — | — | US | disclosed |
| US-20060166857-A1 | 4,8-Dimethyl-7-nonen-2-one and 4,8-dimethylnonan-2-one used as perfumes | SYMRISE GMBH & CO. KG (DE) | 2006-07-27 | — | — | US | disclosed |
| JP-H11189611-A | ELECTRON-BEAM-CURING RESIN COMPOSITION AND HIGHLY GLOSSY SHEETY COMPOSITE MATERIAL OBTAINED THEREFROM | OJI PAPER CO LTD | 1999-07-13 | — | — | JP | disclosed |
| JP-H1129525-A | NEW CYCLOPENTYL ACRYLATE COMPOUND AND ITS PRODUCTION | NIPPON ZEON CO LTD | 1999-02-02 | — | — | JP | disclosed |
| US-4211867-A | ANTISECRETORY AGENTS, HYPOGLYCEMIC AGENTS, ANTIARRHYTHMIA AGENTS | MCNEIL LABORATORIES, INCORPORATED (US) | 1980-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11634659-B2 | Fragrances with rose scent | NR1H2, DUOX2, AOX1 | ALDH1A1 130/4885 |
| US-20210324300-A1 | NOVEL FRAGRANCES WITH ROSE SCENT | NR1H2, DUOX2, AOX1 | ALDH1A1 173/4885 |
| US-20240141254-A1 | 2,6,6-TRIMETHYL-NORPINAN-2-OL AS AN ODORIFEROUS SUBSTANCE | OR10J3, OR51E2, SRD5A2 | ALDH1A1 88/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.